4.5 Article

Neuronal inclusion protein TDP-43 has no primary genetic role in FTD and ALS

Journal

NEUROBIOLOGY OF AGING
Volume 30, Issue 8, Pages 1329-1331

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.neurobiolaging.2007.11.002

Keywords

TDP-43; TARDBP; Frontotemporal dementia; Amyotrophic lateral sclerosis; Genetics

Funding

  1. Special Research Fund of the University of Antwerp
  2. Fund for Scientific Research Flanders (FWO-F)
  3. Institute for Science and Technology - Flanders (IWT-F)
  4. Interuniversity Attraction Poles program (IUAP) [P6/43]
  5. Belgian Science Policy Office
  6. Stichting Alzheimer Onderzoek (SAO) and a Zenith award of the Alzheimer's Association USA
  7. Medical Research Foundation Antwerp and Neurosearch Antwerp

Ask authors/readers for more resources

The nuclear TAR DNA binding protein (TDP-43) is deposited in ubiquitin-positive inclusions in frontotemporal dementia (FTD) and annyotrophic lateral sclerosis (ALS), two clinicopathologically overlapping neurodegenerative diseases. In this study we excluded mutations and copy number variations in the gene encoding TDP-43 (TARDBP) from an extended series of 173 FTD and 237 ALS patients. Further, we did Dot identify association of common genetic variants in these patients. Our data implicate that TDP-43 has no primary genetic role in the pathophysiological mechanisms underlying central nervous system neurodegeneration in these diseases. (C) 2007 Elsevier Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available